Tenofovir is more potent over entecavir in reducing the viral load in patients of hepatitis B reactivation presenting as Acute on Chronic Liver Failure (ACLF)-Results of multination study from APASL-ACLF Research Consortium (AARC)
单位:[1]ILBS, Hepatology, NewDelhi, India[2]Bangabandhu Sheikh Mujib Medical university, Dhaka,Bangladesh[3]Tongji Hospital, Tongji Medical College[4]Beijing You′anHospital/Translational Hepatology Institute Capital Medical University[5302]Millitary Hospital Beijing, China[6]Hospital Selayang, Bata Caves,Selangor[7]Aga Khan University Hospital, Karachi[8]Medistra Hospital,Jakarta, Indonesia[9]Nork Clinical Hospital of Infectious DiseaseArmenia[10]Hallym University College of Medicine, South Korea/BeijingFriendship Hospital, Capital University, Beijing, China首都医科大学附属北京友谊医院[11]Yong Loo LinSchool of Medicine, National University of Singapore[12]PGIMER,Chandigarh, India[13]Humanity and Health Medical Group, China[14]IMS&SUM Hospital, Odisa[15]KEM Hospital and Seth GSMC[16]St JohnMedical College, Bangalore, India[17]Queen Mary Hospital Hong Kong,China[18]Ziauddin University Hospital, Karachi[19]Bombay Hospital &Medical Research Center, Mumbai, India[20]Sir Salimullah MedicalCollege, Mitford Hospital Bangladesh[21]Chulalongkorn University,Bangkok[22]Ankara University School of Medicine[23]CMC, Vellore, India[24]Cardinal Santos Medical Center 10Wilson St. GreenhillsWest San JuanCity, Metro Manila, Philippines[25]Global Hospital, Mumbai, India[26]ILBS[27]ILBS, Hepatology
Ahmad J.,Choudhury A.,Kumar M.,et al.Tenofovir is more potent over entecavir in reducing the viral load in patients of hepatitis B reactivation presenting as Acute on Chronic Liver Failure (ACLF)-Results of multination study from APASL-ACLF Research Consortium (AARC)[J].JOURNAL of HEPATOLOGY.2018,68:S245-S245.doi:10.1016/S0168-8278(18)30707-4.
APA:
Ahmad, J.,Choudhury, A.,Kumar, M.,Al-Mahtab, M.,Rahman, S....&Sarin, S. K..(2018).Tenofovir is more potent over entecavir in reducing the viral load in patients of hepatitis B reactivation presenting as Acute on Chronic Liver Failure (ACLF)-Results of multination study from APASL-ACLF Research Consortium (AARC).JOURNAL of HEPATOLOGY,68,
MLA:
Ahmad, J.,et al."Tenofovir is more potent over entecavir in reducing the viral load in patients of hepatitis B reactivation presenting as Acute on Chronic Liver Failure (ACLF)-Results of multination study from APASL-ACLF Research Consortium (AARC)".JOURNAL of HEPATOLOGY 68.(2018):S245-S245